In the future, large sample sizes, repeated experiments and clinical trials are still needed to further confirm the effect of GLP-1RA on the prognosis of patients with tumors
The overall GLP-1 class maintains a 5-10% discontinuation rate, which compares favorably to many other chronic disease medications ^6
Healthy-user bias arises when users of preventive medications are healthier due to factors other than medication effect
While the weight-reducing effects of GLP-1 agonists are well documented in metabolic disorders, there are limited data regarding their use in managing endocrine therapy-associated weight gain
If you experience severe symptoms such as chest pain, severe shortness of breath, or fainting, seek emergency medical attention immediately
Your first dose of tirzepatide starts at 2.5 mg, taken once weekly